<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ETM</journal-id>
<journal-title-group>
<journal-title>Experimental and Therapeutic Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1792-0981</issn>
<issn pub-type="epub">1792-1015</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/etm.2017.5648</article-id>
<article-id pub-id-type="publisher-id">ETM-0-0-5648</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Pine needle oil induces G2/M arrest of HepG2 cells by activating the ATM pathway</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Qiu</surname><given-names>Bing</given-names></name>
<xref rid="af1-etm-0-0-5648" ref-type="aff">1</xref>
<xref rid="fn1-etm-0-0-5648" ref-type="author-notes">&#x002A;</xref>
<xref rid="c1-etm-0-0-5648" ref-type="corresp"/></contrib>
<contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Wei</given-names></name>
<xref rid="af2-etm-0-0-5648" ref-type="aff">2</xref>
<xref rid="fn1-etm-0-0-5648" ref-type="author-notes">&#x002A;</xref></contrib>
<contrib contrib-type="author"><name><surname>Qiu</surname><given-names>Wenliang</given-names></name>
<xref rid="af1-etm-0-0-5648" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Mu</surname><given-names>Wenling</given-names></name>
<xref rid="af1-etm-0-0-5648" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Qin</surname><given-names>Yujing</given-names></name>
<xref rid="af1-etm-0-0-5648" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Zhu</surname><given-names>Yongcui</given-names></name>
<xref rid="af1-etm-0-0-5648" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Jianying</given-names></name>
<xref rid="af1-etm-0-0-5648" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Qingyi</given-names></name>
<xref rid="af3-etm-0-0-5648" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author"><name><surname>Liu</surname><given-names>Dongjie</given-names></name>
<xref rid="af1-etm-0-0-5648" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Qu</surname><given-names>Zhangyi</given-names></name>
<xref rid="af4-etm-0-0-5648" ref-type="aff">4</xref>
<xref rid="c2-etm-0-0-5648" ref-type="corresp"/></contrib>
</contrib-group>
<aff id="af1-etm-0-0-5648"><label>1</label>Department of Gastroenterology, Heilongjiang Provincial Hospital, Harbin, Heilongjiang 150036, P.R. China</aff>
<aff id="af2-etm-0-0-5648"><label>2</label>Department of Gastroenterology, The First Affiliated Hospital of Jiamusi University, Jiamusi, Heilongjiang 154002, P.R. China</aff>
<aff id="af3-etm-0-0-5648"><label>3</label>Center for Computational and Integrative Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA</aff>
<aff id="af4-etm-0-0-5648"><label>4</label>Department of Hygienic Microbiology, Public Health College, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China</aff>
<author-notes>
<corresp id="c1-etm-0-0-5648"><italic>Correspondence to</italic>: Dr Bing Qiu, Department of Gastroenterology, Heilongjiang Provincial Hospital, 82 Zhongshan Road, Harbin, Heilongjiang 150036, P.R. China, E-mail: <email>bingqiu07@163.com</email></corresp>
<corresp id="c2-etm-0-0-5648">Professor Zhangyi Qu, Department of Hygienic Microbiology, Public Health College, Harbin Medical University, 157 Baojian Road, Harbin, Heilongjiang 150081, P.R. China, E-mail: <email>hmu635@126.com</email></corresp>
<fn id="fn1-etm-0-0-5648"><label>&#x002A;</label><p>Contributed equally</p></fn>
</author-notes>
<pub-date pub-type="ppub">
<month>02</month>
<year>2018</year></pub-date>
<pub-date pub-type="epub">
<day>15</day>
<month>12</month>
<year>2017</year></pub-date>
<volume>15</volume>
<issue>2</issue>
<fpage>1975</fpage>
<lpage>1981</lpage>
<history>
<date date-type="received"><day>06</day><month>01</month><year>2017</year></date>
<date date-type="accepted"><day>23</day><month>08</month><year>2017</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; Qiu et al.</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license>
</permissions>
<abstract>
<p>Over the last two decades, inducing DNA damage of cancer cells by natural medicines has become a research hotspot in the field of cancer treatment. Although various natural medicines have anticancer effects, very few studies have been conducted to explore the anti-cancer effect of pine needle oil. In the present study, the role of pine needle oil in inducing G2/M arrest in HepG2 cells was investigated. The data revealed that pine needle oil could induce DNA damage in a dose-dependent manner. In the pine needle oil-treated HepG2 cells, the protein levels of phosphorylated (p)-ataxia-telangiectasia mutated (ATM), &#x03B3;-H2A histone family, member X, p-p53, p-checkpoint kinase 2 and p-cell division cycle 25C were evidently increased, indicating that pine needle oil facilitated G2/M arrest in HepG2 cells through the ATM pathway. In response to the treatment with pine needle oil, ATM was activated in HepG2 cells, which subsequently phosphorylated downstream targets and induced G2/M arrest. In summary, the data of the present study indicated that pine needle oil induces G2/M arrest in HepG2 cells by facilitating ATM activation.</p>
</abstract>
<kwd-group>
<kwd>pine needle oil</kwd>
<kwd>DNA damage</kwd>
<kwd>G2/M arrest</kwd>
<kwd>ataxia-telangiectasia mutated</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Liver cancer is one of the most common types of malignant tumor and is also one of the leading causes of cancer mortality, particularly in East Asia and Sub-Saharan Africa (<xref rid="b1-etm-0-0-5648" ref-type="bibr">1</xref>). Liver cancer has become an increasing threat to human health. The number of liver cancer mortalities is evidently increasing worldwide each year, and the 5-year survival rate is &#x003C;9&#x0025; (<xref rid="b2-etm-0-0-5648" ref-type="bibr">2</xref>). Additionally, the most common therapeutic options for liver cancer are surgery and chemotherapy. Therefore, it is necessary to develop novel effective drugs or preventive therapies against human hepatoma (<xref rid="b3-etm-0-0-5648" ref-type="bibr">3</xref>). Pine tree is evergreen and needle-leafed, and its various parts, including the leaf, cones, cortices and pollen, have been used as a health-promoting food and complementary therapy (<xref rid="b4-etm-0-0-5648" ref-type="bibr">4</xref>,<xref rid="b5-etm-0-0-5648" ref-type="bibr">5</xref>). Pine needle has been demonstrated to contain active components that present biological effects in several studies (<xref rid="b6-etm-0-0-5648" ref-type="bibr">6</xref>&#x2013;<xref rid="b9-etm-0-0-5648" ref-type="bibr">9</xref>). As a pine needle extract, pine needle oil has demonstrated anticancer effects and has been used as an anticancer agent in traditional Chinese medicine (<xref rid="b10-etm-0-0-5648" ref-type="bibr">10</xref>).</p>
<p>Genomic stability is monitored throughout the cell cycle. DNA damages may result from errors during replication, by-products of metabolism, general toxic drugs or ionizing radiation (<xref rid="b11-etm-0-0-5648" ref-type="bibr">11</xref>). There are two major cell cycle checkpoints, namely G1/S and G2/M, that ensure proper cell cycle progression (<xref rid="b12-etm-0-0-5648" ref-type="bibr">12</xref>). As a critical factor to maintain genomic stability, G2/M cell cycle arrest occurs when DNA is damaged, which provides an opportunity for DNA repair and prevents cells from entering mitosis (<xref rid="b13-etm-0-0-5648" ref-type="bibr">13</xref>,<xref rid="b14-etm-0-0-5648" ref-type="bibr">14</xref>). As a serine/threonine protein kinase, ataxia-telangiectasia mutated (ATM) phosphorylates several key proteins that activate the DNA damage checkpoint, leading to cell cycle arrest, DNA repair or apoptosis (<xref rid="b15-etm-0-0-5648" ref-type="bibr">15</xref>). Several of these target proteins, including p53, checkpoint kinase 2 (CHK2), breast cancer 1, nibrin 1 and H2A histone family, member X (H2AX), are tumor suppressors (<xref rid="b13-etm-0-0-5648" ref-type="bibr">13</xref>,<xref rid="b16-etm-0-0-5648" ref-type="bibr">16</xref>&#x2013;<xref rid="b18-etm-0-0-5648" ref-type="bibr">18</xref>). Therefore, dysregulation of ATM may cause defective repair of DNA damage, which results in the development of various types of cancer (<xref rid="b19-etm-0-0-5648" ref-type="bibr">19</xref>,<xref rid="b20-etm-0-0-5648" ref-type="bibr">20</xref>). The present study examined the effect of pine needle oil on the proliferation of HepG2 cells and the possible molecular mechanism underlying this effect.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Materials</title>
<p>Pine needle oil [dissolved in dimethyl sulfoxide (DMSO), &#x2264;0.1&#x0025;], RNase and propidium iodide (PI) solution were purchased from Sigma-Aldrich (Merck KGaA, Darmstadt, Germany). Anti-&#x03B3;-H2AX (cat no. 05636; 1:1,000) antibody was purchased from EMD Millipore Billerica, MA, USA), ATM (cat no. 2873; 1:500), p-ATM (cat no. 13050; 1:1,000), p-p53 (S15; cat no. 9286; 1:1,000), p-CDC25C (S216; cat no. 4901; 1:500) p-CHK2 (T68; cat no. 2661; 1:1,000) and CHK2 (cat no. 2662; 1:1,000) antibodies were purchased from Cell Signaling Technology, Inc., (Danvers, MA, USA). CDC25C (cat no. sc-327; 1:1,000), &#x03B2;-actin (cat no. sc-47778; 1:1,000), anti-H2AX (cat no. sc-54606; 1:200), p53 (cat no. sc-98; 1:500) antibodies, goat anti-rabbit (cat no. sc-2030; 1:3,000) and anti-mouse secondary (cat no. sc-2031; 1:3,000) antibodies were purchased from Santa Cruz Biotechnology, Inc., (Dallas, TX, USA). Protein extraction solution kit was purchased from Beijing SBS Genetech Co., Ltd., (Beijing, China). Dulbecco&#x0027;s modified Eagle&#x0027;s medium and bovine serum albumin were purchased from Gibco (Thermo Fisher Scientific, Inc., Waltham, MA, USA). The HepG2 cell line was purchased from the China Center for Type Culture Collection of Wuhan University (Wuhan, China). This cell line was originally thought to be a hepatocellular carcinoma, but is now known to be a hepatoblastoma cell line (<xref rid="b21-etm-0-0-5648" ref-type="bibr">21</xref>).</p>
</sec>
<sec>
<title>Cell culture</title>
<p>HepG2 cells were cultured in 1&#x00D7; Eagle&#x0027;s Minimum Essential medium (cat no. 10-009-CV; Corning Incorporated, Corning, NY, USA) supplemented with 10&#x0025; FBS (cat no. 35-011-CV; Corning Incorporated). Fresh culture medium was replenished every 2~3 days. Cells were cultured at 37&#x00B0;C with 5&#x0025; CO<sub>2</sub>. Cell splitting was performed as follows: The cell monolayer was rinsed with 1&#x00D7; PBS followed by the addition of 0.05&#x0025; Trypsin-EDTA solution to cover the dish bottom and then cells were incubated at 37&#x00B0;C for ~5 min.</p>
</sec>
<sec>
<title>Flow cytometry</title>
<p>The HepG2 cells were treated with pine needle oil (0.16 and 5.12 mg/ml) or DMSO (0.16 and 5.12 mg/ml) at different concentrations for 48 h at 37&#x00B0;C and then collected and washed with phosphate-buffered saline (PBS) twice. The cells were fixed with 70&#x0025; ice-cold alcohol at 4&#x00B0;C for &#x003E;1 h, rinsed in ice-cold PBS twice, and suspended in 3 ml PBS-containing ribonuclease (100 &#x00B5;g/l; cat no. R6148-25ML, Sigma-Aldrich; Merck KGaA). Following this, HepG2 cells were incubated at 37&#x00B0;C for 30 min and then stained with PI (50 &#x00B5;g/l) for 30 min in the dark. Subsequently, the percentages of cells at different phases of the cell cycle were analyzed by flow cytometry. The excitation wavelength utilized in the measurement was 488 nm (probe: PE-Texas Red, Biolegend, Inc. San Diego, CA, USA). Images were captured using BD FACSDiva software (v8; BD Biosciences, San Jose, CA, USA).</p>
</sec>
<sec>
<title>Western blotting</title>
<p>HepG2 cells treated with pine needle oil or DMSO were collected by centrifugation at 150 &#x00D7; g at room temperature for 10 min and resuspended with lysis buffer at a density of 2&#x00D7;10<sup>6</sup> cells/ml followed by protein extraction using a protein extraction solution kit. Following this, the protein concentration was determined by a bicinchoninic acid assay and proteins were denatured at 95&#x00B0;C for 10 min. A total of 50 &#x00B5;g of protein per lane was loaded into the 12&#x0025; SDS-PAGE and the proteins were transferred onto a polyvinylidene difluoride (PVDF) membrane, followed by blocking with TBST containing 5&#x0025; BSA (cat no. BP1605-100; Thermo Fisher Scientific, Inc.) for 1 h at room temperature. Subsequently, the membrane was incubated with the primary antibodies overnight at 4&#x00B0;C and the PVDF membrane was washed three times with Tris-buffered saline containing 0.1&#x0025; Tween-20 (TBST) prior to incubating with the secondary antibody at room temperature for 1 h. Following incubation, the membrane was washed with TBST three times again and developed using an enhanced chemiluminescence method (Clarity Western ECL Substrate; cat no. 1705060; Bio-Rad Laboratories, Inc., Hercules, CA, USA) (<xref rid="b22-etm-0-0-5648" ref-type="bibr">22</xref>&#x2013;<xref rid="b24-etm-0-0-5648" ref-type="bibr">24</xref>).</p>
</sec>
<sec>
<title>Immunofluorescence staining</title>
<p>HepG2 cells were treated with different doses of pine needle oil (0.16 and 5.12 mg/ml) or DMSO (vehicle control; 1:1,000) for 48 h. Cells were fixed with pre-chilled (&#x2212;20&#x00B0;C) acetone-methanol (50:50&#x0025;) for 15 min. The cells were washed with 1X PBS and then blocked with 5&#x0025; BSA for 1 h at room temperature. Anti-&#x03B3;H2AX antibody (cat no. 05636; 1:200; EMD Millipore) diluted in 5&#x0025; BSA was added onto the slides and incubated at 4&#x00B0;C overnight (~15 h). The slides were then washed twice with 1&#x00D7; PBS (with 0.2&#x0025; Triton), followed by incubation with donkey anti-mouse secondary antibody (cat no. A-21203; 1:5,000; Thermo Fisher Scientific, Inc.) for 1 h at room temperature. The cells were then mounted with anti-fade reagent containing 4&#x2032;,6-diamidino-2-phenylindole. A fluorescent microscope (Carl Zeiss AG, Oberkochen, Germany) was used to image the samples at a magnification of &#x00D7;400 (<xref rid="b25-etm-0-0-5648" ref-type="bibr">25</xref>).</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>Data was analyzed using SPSS 18.0 (SPSS Inc., Chicago, IL, USA). Data analyses were performed using one-way analysis of variance followed by Tukey&#x0027;s test. Error bars represented the mean &#x00B1; standard error of the mean. P&#x003C;0.05 was considered to indicate a statistically significant difference.</p>
</sec>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>Pine needle oil induces cell cycle arrest at the G2/M phase in HepG2 cells</title>
<p>In order to examine whether pine needle oil induced G2/M arrest and contributed to the inhibition of tumor growth, HepG2 cells were used as a cell model, which was treated with pine needle oil at different concentrations (0.16 and 5.12 mg/ml) in the general culture condition. DMSO was used as a vehicle control. As depicted in <xref rid="f1-etm-0-0-5648" ref-type="fig">Fig. 1</xref>, the proportion of cells at the G2/M phase evidently increased in the pine needle oil-treated group compared with the control group. In addition, the number of HepG2 cells at the G2/M phase was significantly increased in the group treated with higher concentration of pine needle oil (5.12 mg/ml) compared with the group treated with a lower concentration of pine needle oil (0.16 mg/ml) (P&#x003C;0.05; <xref rid="tI-etm-0-0-5648" ref-type="table">Table I</xref>). By contrast, the proportion of the cell population at the G0/G1 phase was markedly decreased in the group treated with higher concentration of pine needle oil (5.12 mg/ml) compared with the group treated with a lower concentration of pine needle oil. The data in <xref rid="f1-etm-0-0-5648" ref-type="fig">Fig. 1</xref> and <xref rid="tI-etm-0-0-5648" ref-type="table">Table I</xref> indicate that pine needle oil facilitated G2/M arrest of HepG2 cells in a dose-dependent manner.</p>
</sec>
<sec>
<title>Pine needle oil induces G2/M arrest by activating the ATM pathway</title>
<p>To evaluate whether cell cycle-related proteins, including p53, ATM, H2AX and CHK2, were involved in the pine needle oil-induced G2/M arrest in HepG2 cells, the expression levels of these proteins were assessed by western blotting. As demonstrated in <xref rid="f2-etm-0-0-5648" ref-type="fig">Fig. 2</xref>, following incubation with pine needle oil at various concentrations (0.00, 0.01, 0.16, 5.12 and 40.96 mg/ml), p-ATM (S1981), p-CHK2 (T68), p-p53, p53 and &#x03B3;-H2AX expression levels in HepG2 cells were markedly upregulated. Furthermore, the higher concentration of pine needle oil administrated, the greater the upregulation of these proteins, which indicated that the activation of these proteins by pine needle oil occurred in a dose-dependent manner. These results demonstrate that G2/M arrest was induced by pine needle oil by activation of the ATM pathway in HepG2 cells.</p>
</sec>
<sec>
<title>Pine needle oil induces the expression of &#x03B3;-H2AX in the nucleus of HepG2 cells</title>
<p>To further confirm the upregulation of &#x03B3;-H2AX in HepG2 cells following treatment with pine needle oil, immunostaining was performed with specific antibodies against &#x03B3;-H2AX. As presented in <xref rid="f3-etm-0-0-5648" ref-type="fig">Fig. 3</xref>, without pine needle oil treatment, &#x03B3;-H2AX was not detectable in the nuclei of HepG2 cells. Following pine needle oil treatment at different concentrations, &#x03B3;-H2AX (red) was evidently upregulated in the nuclei in a dose-dependent manner (<xref rid="f3-etm-0-0-5648" ref-type="fig">Fig. 3</xref>).</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>Liver cancer is one of the most commonly diagnosed types of cancer worldwide and the third most common cause of cancer mortality (<xref rid="b26-etm-0-0-5648" ref-type="bibr">26</xref>,<xref rid="b27-etm-0-0-5648" ref-type="bibr">27</xref>). This disease is responsible for ~1 million mortalities per year (<xref rid="b28-etm-0-0-5648" ref-type="bibr">28</xref>). Thus far, the most recognized therapeutic strategies for liver cancer are surgery and chemotherapy. Although tremendous achievements have been made in the treatment of liver cancer over the last two decades, the therapeutic effects of current options of treatment remain unsatisfactory and it is essential to seek more effective treatment methods to improve the prognosis of liver cancer (<xref rid="b29-etm-0-0-5648" ref-type="bibr">29</xref>). Natural medicine, particularly traditional Chinese medicine, is one of the most attractive therapeutic methods used to treat various types of cancer. Recently, efforts have been largely focused on exploring effective natural medicine for the treatment of liver cancer (<xref rid="b30-etm-0-0-5648" ref-type="bibr">30</xref>&#x2013;<xref rid="b33-etm-0-0-5648" ref-type="bibr">33</xref>). Pine needle oil is one such natural medicine that may serve an important role in the treatment of liver cancer (<xref rid="b10-etm-0-0-5648" ref-type="bibr">10</xref>,<xref rid="b34-etm-0-0-5648" ref-type="bibr">34</xref>,<xref rid="b35-etm-0-0-5648" ref-type="bibr">35</xref>). It is extracted and purified from the leaf of the <italic>Pinus</italic>, a member of the Pinaceae family (<xref rid="b36-etm-0-0-5648" ref-type="bibr">36</xref>). Previous studies have revealed that pine needle oil has antioxidant, antimicrobial and anticancer activities (<xref rid="b34-etm-0-0-5648" ref-type="bibr">34</xref>,<xref rid="b37-etm-0-0-5648" ref-type="bibr">37</xref>). However, these studies need to be further validated, as the ability to inhibit the abnormal proliferation and induce apoptosis in human tumor cell lines could be applied to develop more effective anticancer drugs.</p>
<p>During the development of an organism, several types of biological processes are fundamental, including cell proliferation, division and deformation, apoptosis and necrosis (<xref rid="b38-etm-0-0-5648" ref-type="bibr">38</xref>). Regulation of the cell cycle involves processes crucial to cell survival, including the monitoring and repair of genetic damages, as well as the prevention of uncontrolled cell division (<xref rid="b39-etm-0-0-5648" ref-type="bibr">39</xref>). The molecular events that control the cell cycle are ordered and directional. Once certain abnormal activities occur at certain phases of the cell cycle, cells may enter pathological processes, such as programed (<xref rid="b40-etm-0-0-5648" ref-type="bibr">40</xref>&#x2013;<xref rid="b42-etm-0-0-5648" ref-type="bibr">42</xref>). A prevalent view is that uncontrolled cell cycle events are responsible for the initiation and development of tumors. The destruction of cell cycle regulation is a typical feature in the majority of cancer cells (<xref rid="b43-etm-0-0-5648" ref-type="bibr">43</xref>,<xref rid="b44-etm-0-0-5648" ref-type="bibr">44</xref>). Therefore, in order to control cancer, it is critical to correct the mistakes in cell cycle regulation, and the checkpoints provide the opportunity for self-healing of cells prior to mitosis. The G2/M checkpoint, also known as the DNA damage checkpoint, ensures that the cell undergoes all the necessary changes during the S and G2 phases and is ready for cell division (<xref rid="b45-etm-0-0-5648" ref-type="bibr">45</xref>,<xref rid="b46-etm-0-0-5648" ref-type="bibr">46</xref>). Thus, inducing G2/M arrest is an effective strategy of controlling the proliferation of cancer cells. As demonstrated in the present study, the proportion of HepG2 cells at the G2/M phase was markedly elevated when the cells were treated with pine needle oil. The results indicated that pine needle oil induced cell cycle arrest at the G2/M checkpoint in HepG2 cells and inhibited cancer cell growth by interfering with mitotic progression.</p>
<p>DNA damage naturally and frequently occurs due to endogenous and exogenous cellular processes (<xref rid="b47-etm-0-0-5648" ref-type="bibr">47</xref>,<xref rid="b48-etm-0-0-5648" ref-type="bibr">48</xref>). It is a major problem for life since cells must make large investments in DNA repair processes to maintain genomic integrity. The failure of self-healing of DNA damage or the accumulation of DNA damage-related factors may lead to abnormal cell growth that may result in the formation and development of diseases, such as cancer (<xref rid="b49-etm-0-0-5648" ref-type="bibr">49</xref>,<xref rid="b50-etm-0-0-5648" ref-type="bibr">50</xref>). It was reported that DNA damage may activate ATM (<xref rid="b51-etm-0-0-5648" ref-type="bibr">51</xref>,<xref rid="b52-etm-0-0-5648" ref-type="bibr">52</xref>). Furthermore, the activation of ATM subsequently facilitates the activation or phosphorylation of other key proteins that are able to detect DNA damage. Once these downstream proteins perceive the signals of DNA damage, they may trigger programed processes to complete the repair of damaged DNA, induce apoptosis or promote cell cycle arrest (<xref rid="b53-etm-0-0-5648" ref-type="bibr">53</xref>,<xref rid="b54-etm-0-0-5648" ref-type="bibr">54</xref>). Therefore, the ATM pathway serves an important role in maintaining genomic stability and preventing tumorigenesis. Several targets of ATM, including H2AX, p53 and CHK2, are tumor suppressors (<xref rid="b55-etm-0-0-5648" ref-type="bibr">55</xref>,<xref rid="b56-etm-0-0-5648" ref-type="bibr">56</xref>). In response to DNA double-strand breaks (DSB), H2AX may be phosphorylated on serine 139 by ATM. Furthermore, the phosphorylated product of H2AX, namely &#x03B3;-H2AX, is a sensitive target for DSB in cells (<xref rid="b57-etm-0-0-5648" ref-type="bibr">57</xref>,<xref rid="b58-etm-0-0-5648" ref-type="bibr">58</xref>). As a tumor suppressor, p53 has been described as &#x2018;the guardian of the genome&#x2019; due to its role in conserving stability by preventing genomic mutations. Previous studies have revealed that p53 has anticancer function through various mechanisms and is involved in cell cycle arrest in HepG2 cells (<xref rid="b59-etm-0-0-5648" ref-type="bibr">59</xref>&#x2013;<xref rid="b65-etm-0-0-5648" ref-type="bibr">65</xref>). As a protein that also acts as a tumor suppressor, CHK2 regulates cell division in a way to prevent cells from dividing too rapidly or in an uncontrolled manner (<xref rid="b66-etm-0-0-5648" ref-type="bibr">66</xref>,<xref rid="b67-etm-0-0-5648" ref-type="bibr">67</xref>). In 1999, genetic variations of CHK2 were revealed to be associated with inherited cancer susceptibility (<xref rid="b68-etm-0-0-5648" ref-type="bibr">68</xref>). Specifically, Thr68 of CHK2 may be phosphorylated and activated by DNA damage-activated ATM (<xref rid="b69-etm-0-0-5648" ref-type="bibr">69</xref>). The activated CHK2 may then phosphorylate downstream targets, including cell division cycle (CDC)25C phosphatases, which may prevent the cell from entering mitosis by dephosphorylating and activating cyclin B-bound CDC2 (<xref rid="b70-etm-0-0-5648" ref-type="bibr">70</xref>). By preventing mutated or damaged DNA from being passed into daughter cells, CHK2 stops tumors from developing (<xref rid="b71-etm-0-0-5648" ref-type="bibr">71</xref>,<xref rid="b72-etm-0-0-5648" ref-type="bibr">72</xref>).</p>
<p>Treatment of cancer by traditional Chinese medicine has become an important therapeutic strategy for cancer patients (<xref rid="b73-etm-0-0-5648" ref-type="bibr">73</xref>&#x2013;<xref rid="b78-etm-0-0-5648" ref-type="bibr">78</xref>). As a traditional Chinese medicine, pine needle oil has been used for numerous years. It was reported that pine needle oil had antioxidant and antimicrobial activities (<xref rid="b37-etm-0-0-5648" ref-type="bibr">37</xref>). In addition, scientists have revealed that pine needle oil possesses anticancer effects in various cancer cells, such as breast cancer cells (<xref rid="b79-etm-0-0-5648" ref-type="bibr">79</xref>). Previously, Wei <italic>et al</italic> (<xref rid="b34-etm-0-0-5648" ref-type="bibr">34</xref>) demonstrated that pine needle oil could induce the apoptosis of HepG2 cells. However, besides the data that reveals that pine needle oil could induce apoptosis and activity changes of telomerase in the HepG2 cell line (<xref rid="b34-etm-0-0-5648" ref-type="bibr">34</xref>), no further studies have been conducted. Therefore, it is crucial to conduct more in-depth investigations to comprehensively understand the mechanisms underlying the anticancer effect of pine needle oil. The present study indicated that pine needle oil induces G2/M cell cycle arrest and presents its anticancer effect by activating the ATM pathway. The data demonstrated that the expression of p-ATM (S1981), p-CHK2 (T68), p-p53, &#x03B3;-H2AX and CDC25C all increased in a dose-dependent manner in the HepG2 cells that were treated with pine needle oil, implying that pine needle oil induces G2/M arrest by activating the ATM pathway. When the HepG2 cells were treated with pine needle oil, the damaged DNA activated the ATM by autophosphorylation of ATM (S1981), which subsequently facilitated the activation of CHK2, H2AX and p53 by phosphorylation. The activation of these downstream proteins further transfers the signals to other related proteins, which results in cell cycle arrest. Furthermore, it is well recognized that DNA damage may induce the phosphorylation of ATM (<xref rid="b80-etm-0-0-5648" ref-type="bibr">80</xref>,<xref rid="b81-etm-0-0-5648" ref-type="bibr">81</xref>). The confocal laser scanning microscopy data of the present study demonstrated that treatment with pine needle oil could increase p-ATM in the nucleus of HepG2 cells, indicating that DNA damage induced the activation of ATM by phosphorylation in the nucleus. Based on the data provided in the present study, a conclusion may be drawn that pine needle oil induces G2/M cell cycle arrest by activating the ATM signaling pathways, inhibits proliferation, and balances proliferation and apoptosis in HepG2 cells.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>The present study was supported by a grant from the Foundation of Excellent Returned Overseas Students of Heilongjiang in China (grant no. 2015-424) and the Postdoctoral Fellowship of Heilongjiang Province of China (grant no. LBH-Z15152).</p>
</ack>
<ref-list>
<title>References</title>
<ref id="b1-etm-0-0-5648"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Della Corte</surname><given-names>C</given-names></name><name><surname>Triolo</surname><given-names>M</given-names></name><name><surname>Iavarone</surname><given-names>M</given-names></name><name><surname>Sangiovanni</surname><given-names>A</given-names></name></person-group><article-title>Early diagnosis of liver cancer: An appraisal of international recommendations and future perspectives</article-title><source>Liver Int</source><volume>36</volume><fpage>166</fpage><lpage>176</lpage><year>2016</year><pub-id pub-id-type="doi">10.1111/liv.12965</pub-id><pub-id pub-id-type="pmid">26386254</pub-id></element-citation></ref>
<ref id="b2-etm-0-0-5648"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>JG</given-names></name><name><surname>Zhang</surname><given-names>SW</given-names></name></person-group><article-title>Liver cancer epidemic in China: Past, present and future</article-title><source>Semin Cancer Biol</source><volume>21</volume><fpage>59</fpage><lpage>69</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.semcancer.2010.11.002</pub-id><pub-id pub-id-type="pmid">21144900</pub-id></element-citation></ref>
<ref id="b3-etm-0-0-5648"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Midorikawa</surname><given-names>Y</given-names></name><name><surname>Sugiyama</surname><given-names>Y</given-names></name><name><surname>Aburatani</surname><given-names>H</given-names></name></person-group><article-title>Molecular targets for liver cancer therapy: From screening of target genes to clinical trials</article-title><source>Hepatol Res</source><volume>40</volume><fpage>49</fpage><lpage>60</lpage><year>2010</year><pub-id pub-id-type="doi">10.1111/j.1872-034X.2009.00583.x</pub-id><pub-id pub-id-type="pmid">19788683</pub-id></element-citation></ref>
<ref id="b4-etm-0-0-5648"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakagami</surname><given-names>H</given-names></name><name><surname>Yoshihara</surname><given-names>M</given-names></name><name><surname>Fujimaki</surname><given-names>M</given-names></name><name><surname>Wada</surname><given-names>C</given-names></name><name><surname>Komatsu</surname><given-names>N</given-names></name><name><surname>Nakashima</surname><given-names>H</given-names></name><name><surname>Murakami</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>N</given-names></name></person-group><article-title>Effect of pine seed shell extract on microbial and viral infection</article-title><source>In Vivo</source><volume>6</volume><fpage>13</fpage><lpage>16</lpage><year>1992</year><pub-id pub-id-type="pmid">1627738</pub-id></element-citation></ref>
<ref id="b5-etm-0-0-5648"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname><given-names>Z</given-names></name><name><surname>Mu</surname><given-names>Y</given-names></name><name><surname>Gulati</surname><given-names>O</given-names></name></person-group><article-title>Treatment of melasma with pycnogenol</article-title><source>Phytother Res</source><volume>16</volume><fpage>567</fpage><lpage>571</lpage><year>2002</year><pub-id pub-id-type="doi">10.1002/ptr.1085</pub-id><pub-id pub-id-type="pmid">12237816</pub-id></element-citation></ref>
<ref id="b6-etm-0-0-5648"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Politeo</surname><given-names>O</given-names></name><name><surname>Skocibusic</surname><given-names>M</given-names></name><name><surname>Maravic</surname><given-names>A</given-names></name><name><surname>Ruscic</surname><given-names>M</given-names></name><name><surname>Milos</surname><given-names>M</given-names></name></person-group><article-title>Chemical composition and antimicrobial activity of the essential oil of endemic Dalmatian black pine (<italic>Pinus nigra ssp. dalmatica</italic>)</article-title><source>Chem Biodivers</source><volume>8</volume><fpage>540</fpage><lpage>547</lpage><year>2011</year><pub-id pub-id-type="doi">10.1002/cbdv.201000185</pub-id><pub-id pub-id-type="pmid">21404437</pub-id></element-citation></ref>
<ref id="b7-etm-0-0-5648"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>HG</given-names></name><name><surname>Lee</surname><given-names>HW</given-names></name><name><surname>Han</surname><given-names>JM</given-names></name><name><surname>Lee</surname><given-names>SK</given-names></name><name><surname>Kim</surname><given-names>DW</given-names></name><name><surname>Saravanakumar</surname><given-names>A</given-names></name><name><surname>Son</surname><given-names>CG</given-names></name></person-group><article-title>Hippocampal memory enhancing activity of pine needle extract against scopolamine-induced amnesia in a mouse model</article-title><source>Sci Rep</source><volume>5</volume><fpage>9651</fpage><year>2015</year><pub-id pub-id-type="doi">10.1038/srep09651</pub-id><pub-id pub-id-type="pmid">25974329</pub-id></element-citation></ref>
<ref id="b8-etm-0-0-5648"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>He</surname><given-names>L</given-names></name><name><surname>Yan</surname><given-names>M</given-names></name><name><surname>Zheng</surname><given-names>GY</given-names></name><name><surname>Liu</surname><given-names>XY</given-names></name></person-group><article-title>Effects of polyprenols from pine needles of <italic>Pinus massoniana</italic> on ameliorating cognitive impairment in a D-galactose-induced mouse model</article-title><source>Age (Dordr)</source><volume>36</volume><fpage>9676</fpage><year>2014</year><pub-id pub-id-type="doi">10.1007/s11357-014-9676-6</pub-id><pub-id pub-id-type="pmid">24981114</pub-id></element-citation></ref>
<ref id="b9-etm-0-0-5648"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>CL</given-names></name><name><surname>Chen</surname><given-names>CM</given-names></name><name><surname>Chang</surname><given-names>YZ</given-names></name><name><surname>Liu</surname><given-names>GY</given-names></name><name><surname>Hung</surname><given-names>HC</given-names></name><name><surname>Hsieh</surname><given-names>TY</given-names></name><name><surname>Lin</surname><given-names>CL</given-names></name></person-group><article-title>Pine (<italic>Pinus morrisonicola</italic> Hayata) needle extracts sensitize GBM8901 human glioblastoma cells to temozolomide by downregulating autophagy and O(6)-methylguanine-DNA methyltransferase expression</article-title><source>J Agric Food Chem</source><volume>62</volume><fpage>10458</fpage><lpage>10467</lpage><year>2014</year><pub-id pub-id-type="doi">10.1021/jf501234b</pub-id><pub-id pub-id-type="pmid">25293350</pub-id></element-citation></ref>
<ref id="b10-etm-0-0-5648"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>WQ</given-names></name><name><surname>Xu</surname><given-names>B</given-names></name><name><surname>Mao</surname><given-names>JW</given-names></name><name><surname>Wei</surname><given-names>FX</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Jin</surname><given-names>XB</given-names></name><name><surname>Zhang</surname><given-names>LR</given-names></name></person-group><article-title>Inhibitory effects of &#x03B1;-pinene on hepatoma carcinoma cell proliferation</article-title><source>Asian Pac J Cancer Prev</source><volume>15</volume><fpage>3293</fpage><lpage>3297</lpage><year>2014</year><pub-id pub-id-type="doi">10.7314/APJCP.2014.15.7.3293</pub-id><pub-id pub-id-type="pmid">24815485</pub-id></element-citation></ref>
<ref id="b11-etm-0-0-5648"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x0027;Neill</surname><given-names>JP</given-names></name></person-group><article-title>DNA damage, DNA repair, cell proliferation, and DNA replication: How do gene mutations result?</article-title><source>Proc Natl Acad Sci USA</source><volume>97</volume><fpage>11137</fpage><lpage>11139</lpage><year>2000</year><pub-id pub-id-type="doi">10.1073/pnas.210383397</pub-id><pub-id pub-id-type="pmid">11016974</pub-id></element-citation></ref>
<ref id="b12-etm-0-0-5648"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agarwal</surname><given-names>ML</given-names></name><name><surname>Agarwal</surname><given-names>A</given-names></name><name><surname>Taylor</surname><given-names>WR</given-names></name><name><surname>Stark</surname><given-names>GR</given-names></name></person-group><article-title>p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human</article-title><source>Proc Natl Acad Sci USA</source><volume>92</volume><fpage>8493</fpage><lpage>8497</lpage><year>1995</year><pub-id pub-id-type="doi">10.1073/pnas.92.18.8493</pub-id><pub-id pub-id-type="pmid">7667317</pub-id></element-citation></ref>
<ref id="b13-etm-0-0-5648"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selvarajah</surname><given-names>J</given-names></name><name><surname>Elia</surname><given-names>A</given-names></name><name><surname>Carroll</surname><given-names>VA</given-names></name><name><surname>Moumen</surname><given-names>A</given-names></name></person-group><article-title>DNA damage-induced S and G2/M cell cycle arrest requires mTORC2-dependent regulation of Chk1</article-title><source>Oncotarget</source><volume>6</volume><fpage>427</fpage><lpage>440</lpage><year>2015</year><pub-id pub-id-type="doi">10.18632/oncotarget.2813</pub-id><pub-id pub-id-type="pmid">25460505</pub-id></element-citation></ref>
<ref id="b14-etm-0-0-5648"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hua</surname><given-names>KF</given-names></name><name><surname>Liao</surname><given-names>PC</given-names></name><name><surname>Fang</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>FL</given-names></name><name><surname>Yang</surname><given-names>YL</given-names></name><name><surname>Chen</surname><given-names>YL</given-names></name><name><surname>Chiu</surname><given-names>YC</given-names></name><name><surname>Liu</surname><given-names>ML</given-names></name><name><surname>Lam</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>SH</given-names></name></person-group><article-title>Generation of reactive oxygen species by polyenylpyrroles derivatives causes DNA damage leading to G2/M arrest and apoptosis in human oral squamous cell carcinoma cells</article-title><source>PLoS One</source><volume>8</volume><fpage>e67603</fpage><year>2013</year><pub-id pub-id-type="doi">10.1371/journal.pone.0067603</pub-id><pub-id pub-id-type="pmid">23840748</pub-id></element-citation></ref>
<ref id="b15-etm-0-0-5648"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vecchio</surname><given-names>D</given-names></name><name><surname>Frosina</surname><given-names>G</given-names></name></person-group><article-title>Targeting the ataxia telangiectasia mutated protein in cancer therapy</article-title><source>Curr Drug Targets</source><volume>17</volume><fpage>139</fpage><lpage>153</lpage><year>2016</year><pub-id pub-id-type="doi">10.2174/1389450115666141110154621</pub-id><pub-id pub-id-type="pmid">25382204</pub-id></element-citation></ref>
<ref id="b16-etm-0-0-5648"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cosentino</surname><given-names>C</given-names></name><name><surname>Grieco</surname><given-names>D</given-names></name><name><surname>Costanzo</surname><given-names>V</given-names></name></person-group><article-title>ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair</article-title><source>EMBO J</source><volume>30</volume><fpage>546</fpage><lpage>555</lpage><year>2011</year><pub-id pub-id-type="doi">10.1038/emboj.2010.330</pub-id><pub-id pub-id-type="pmid">21157431</pub-id></element-citation></ref>
<ref id="b17-etm-0-0-5648"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodarzi</surname><given-names>AA</given-names></name><name><surname>Noon</surname><given-names>AT</given-names></name><name><surname>Deckbar</surname><given-names>D</given-names></name><name><surname>Ziv</surname><given-names>Y</given-names></name><name><surname>Shiloh</surname><given-names>Y</given-names></name><name><surname>L&#x00F6;brich</surname><given-names>M</given-names></name><name><surname>Jeggo</surname><given-names>PA</given-names></name></person-group><article-title>ATM signaling facilitates repair of DNA double-strand breaks associated with heterochromatin</article-title><source>Mol Cell</source><volume>31</volume><fpage>167</fpage><lpage>177</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/j.molcel.2008.05.017</pub-id><pub-id pub-id-type="pmid">18657500</pub-id></element-citation></ref>
<ref id="b18-etm-0-0-5648"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enns</surname><given-names>L</given-names></name><name><surname>Rasouli-Nia</surname><given-names>A</given-names></name><name><surname>Hendzel</surname><given-names>M</given-names></name><name><surname>Marples</surname><given-names>B</given-names></name><name><surname>Weinfeld</surname><given-names>M</given-names></name></person-group><article-title>Association of ATM activation and DNA repair with induced radioresistance after low-dose irradiation</article-title><source>Radiat Prot Dosimetry</source><volume>166</volume><fpage>131</fpage><lpage>136</lpage><year>2015</year><pub-id pub-id-type="doi">10.1093/rpd/ncv203</pub-id><pub-id pub-id-type="pmid">25904696</pub-id></element-citation></ref>
<ref id="b19-etm-0-0-5648"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bay</surname><given-names>JO</given-names></name><name><surname>Uhrhammer</surname><given-names>N</given-names></name><name><surname>Stoppa-Lyonnet</surname><given-names>D</given-names></name><name><surname>Hall</surname><given-names>J</given-names></name></person-group><article-title>Role of the ATM gene in genetic predisposition to cancer</article-title><source>Bull Cancer</source><volume>87</volume><fpage>29</fpage><lpage>34</lpage><year>2000</year><comment>(In French)</comment><pub-id pub-id-type="pmid">10673629</pub-id></element-citation></ref>
<ref id="b20-etm-0-0-5648"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunet</surname><given-names>J</given-names></name><name><surname>Guti&#x00E9;rrez-Enriquez</surname><given-names>S</given-names></name><name><surname>Torres</surname><given-names>A</given-names></name><name><surname>B&#x00E9;rez</surname><given-names>V</given-names></name><name><surname>Sanjos&#x00E9;</surname><given-names>S</given-names></name><name><surname>Galceran</surname><given-names>J</given-names></name><name><surname>Izquierdo</surname><given-names>A</given-names></name><name><surname>Men&#x00E9;ndez</surname><given-names>JA</given-names></name><name><surname>Gum&#x00E0;</surname><given-names>J</given-names></name><name><surname>Borr&#x00E0;s</surname><given-names>J</given-names></name></person-group><article-title>ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations</article-title><source>Clin Genet</source><volume>73</volume><fpage>465</fpage><lpage>473</lpage><year>2008</year><pub-id pub-id-type="doi">10.1111/j.1399-0004.2008.00987.x</pub-id><pub-id pub-id-type="pmid">18384426</pub-id></element-citation></ref>
<ref id="b21-etm-0-0-5648"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x00F3;pez-Terrada</surname><given-names>D</given-names></name><name><surname>Cheung</surname><given-names>SW</given-names></name><name><surname>Finegold</surname><given-names>MJ</given-names></name><name><surname>Knowles</surname><given-names>BB</given-names></name></person-group><article-title>Hep G2 is a hepatoblastoma-derived cell line</article-title><source>Hum Pathol</source><volume>40</volume><fpage>1512</fpage><lpage>1515</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.humpath.2009.07.003</pub-id></element-citation></ref>
<ref id="b22-etm-0-0-5648"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Qiu</surname><given-names>Z</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Shi</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>W</given-names></name></person-group><article-title>CRTC2 and PROM1 expression in non-small cell lung cancer: Analysis by Western blot and immunohistochemistry</article-title><source>Tumour Biol</source><volume>35</volume><fpage>11719</fpage><lpage>11726</lpage><year>2014</year><pub-id pub-id-type="doi">10.1007/s13277-014-2011-0</pub-id><pub-id pub-id-type="pmid">25256670</pub-id></element-citation></ref>
<ref id="b23-etm-0-0-5648"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name></person-group><article-title>Scutellarin-induced apoptosis in HepG2 hepatocellular carcinoma cells via a STAT3 pathway</article-title><source>Phytother Res</source><volume>27</volume><fpage>1524</fpage><lpage>1528</lpage><year>2013</year><pub-id pub-id-type="pmid">23192830</pub-id></element-citation></ref>
<ref id="b24-etm-0-0-5648"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>CG</given-names></name><name><surname>Banerjee</surname><given-names>R</given-names></name></person-group><article-title>Tumor necrosis factor-alpha-induced targeted proteolysis of cystathionine beta-synthase modulates redox homeostasis</article-title><source>J Biol Chem</source><volume>278</volume><fpage>16802</fpage><lpage>16808</lpage><year>2003</year><pub-id pub-id-type="doi">10.1074/jbc.M212376200</pub-id><pub-id pub-id-type="pmid">12615917</pub-id></element-citation></ref>
<ref id="b25-etm-0-0-5648"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>F</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Tao</surname><given-names>L</given-names></name><name><surname>Tang</surname><given-names>D</given-names></name></person-group><article-title>Both ERK1 and ERK2 kinases promote G2/M arrest in etoposide-treated MCF7 cells by facilitating ATM activation</article-title><source>Cell Signal</source><volume>22</volume><fpage>1783</fpage><lpage>1789</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.cellsig.2010.07.007</pub-id><pub-id pub-id-type="pmid">20637859</pub-id></element-citation></ref>
<ref id="b26-etm-0-0-5648"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryder</surname><given-names>S</given-names></name><name><surname>Rizzi</surname><given-names>P</given-names></name><name><surname>Karani</surname><given-names>J</given-names></name><name><surname>Williams</surname><given-names>R</given-names></name></person-group><article-title>Therapy for hepatocellular-carcinoma (review)</article-title><source>Int J Oncol</source><volume>6</volume><fpage>1113</fpage><lpage>1122</lpage><year>1995</year><pub-id pub-id-type="pmid">21556648</pub-id></element-citation></ref>
<ref id="b27-etm-0-0-5648"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wen</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>He</surname><given-names>Q</given-names></name><name><surname>Feng</surname><given-names>D</given-names></name></person-group><article-title>Loss of plexin-B3 in hepatocellular carcinoma</article-title><source>Exp Ther Med</source><volume>9</volume><fpage>1247</fpage><lpage>1252</lpage><year>2015</year><pub-id pub-id-type="doi">10.3892/etm.2015.2243</pub-id><pub-id pub-id-type="pmid">25780417</pub-id></element-citation></ref>
<ref id="b28-etm-0-0-5648"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torre</surname><given-names>LA</given-names></name><name><surname>Bray</surname><given-names>F</given-names></name><name><surname>Siegel</surname><given-names>RL</given-names></name><name><surname>Ferlay</surname><given-names>J</given-names></name><name><surname>Lortet-Tieulent</surname><given-names>J</given-names></name><name><surname>Jemal</surname><given-names>A</given-names></name></person-group><article-title>Global cancer statistics, 2012</article-title><source>CA Cancer J Clin</source><volume>65</volume><fpage>87</fpage><lpage>108</lpage><year>2015</year><pub-id pub-id-type="doi">10.3322/caac.21262</pub-id><pub-id pub-id-type="pmid">25651787</pub-id></element-citation></ref>
<ref id="b29-etm-0-0-5648"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mokdad</surname><given-names>AA</given-names></name><name><surname>Singal</surname><given-names>AG</given-names></name><name><surname>Yopp</surname><given-names>AC</given-names></name></person-group><article-title>JAMA PATIENT PAGE. Treatment of liver cancer</article-title><source>JAMA</source><volume>315</volume><fpage>100</fpage><year>2016</year><pub-id pub-id-type="doi">10.1001/jama.2015.15431</pub-id><pub-id pub-id-type="pmid">26746473</pub-id></element-citation></ref>
<ref id="b30-etm-0-0-5648"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>F</given-names></name><name><surname>Khan</surname><given-names>TJ</given-names></name><name><surname>Kalamegam</surname><given-names>G</given-names></name><name><surname>Pushparaj</surname><given-names>PN</given-names></name><name><surname>Chaudhary</surname><given-names>A</given-names></name><name><surname>Abuzenadah</surname><given-names>A</given-names></name><name><surname>Kumosani</surname><given-names>T</given-names></name><name><surname>Barbour</surname><given-names>E</given-names></name><name><surname>Al-Qahtani</surname><given-names>M</given-names></name></person-group><article-title>Anti-cancer effects of Ajwa dates (Phoenix dactylifera L.) in diethylnitrosamine induced hepatocellular carcinoma in Wistar rats</article-title><source>BMC Complement Altern Med</source><volume>17</volume><fpage>418</fpage><year>2017</year><pub-id pub-id-type="doi">10.1186/s12906-017-1926-6</pub-id><pub-id pub-id-type="pmid">28830415</pub-id></element-citation></ref>
<ref id="b31-etm-0-0-5648"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>W</given-names></name><name><surname>Ba</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Yuan</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Duan</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name></person-group><article-title>A natural CCR2 antagonist relieves Tumor-associated Macrophage-mediated immunosuppression to produce a therapeutic effect for liver cancer</article-title><source>EBioMedicine</source><volume>22</volume><fpage>58</fpage><lpage>67</lpage><year>2017</year><pub-id pub-id-type="doi">10.1016/j.ebiom.2017.07.014</pub-id><pub-id pub-id-type="pmid">28754304</pub-id></element-citation></ref>
<ref id="b32-etm-0-0-5648"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Tian</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Duan</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>You</surname><given-names>L</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Combretastatin A-1 phosphate, a microtubule inhibitor, acts on both hepatocellular carcinoma cells and tumor-associated macrophages by inhibiting the Wnt/&#x03B2;-catenin pathway</article-title><source>Cancer Lett</source><volume>380</volume><fpage>134</fpage><lpage>143</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.canlet.2016.06.020</pub-id><pub-id pub-id-type="pmid">27349166</pub-id></element-citation></ref>
<ref id="b33-etm-0-0-5648"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kant</surname><given-names>R</given-names></name><name><surname>Yen</surname><given-names>CH</given-names></name><name><surname>Lu</surname><given-names>CK</given-names></name><name><surname>Lin</surname><given-names>YC</given-names></name><name><surname>Li</surname><given-names>JH</given-names></name><name><surname>Chen</surname><given-names>YM</given-names></name></person-group><article-title>Identification of 1,2,3,4,6-Penta-O-galloyl-&#x03B2;-d-glucopyranoside as a Glycine N-Methyltransferase enhancer by High-throughput screening of natural products inhibits hepatocellular carcinoma</article-title><source>Int J Mol Sci</source><volume>17</volume><comment>pii: E669</comment><year>2016</year><pub-id pub-id-type="doi">10.3390/ijms17050669</pub-id><pub-id pub-id-type="pmid">27153064</pub-id></element-citation></ref>
<ref id="b34-etm-0-0-5648"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>FX</given-names></name><name><surname>Li</surname><given-names>MY</given-names></name><name><surname>Song</surname><given-names>YH</given-names></name><name><surname>Li</surname><given-names>HZ</given-names></name></person-group><article-title>Apoptosis and activity changes of telomerase induced by essential oil from pine needles in HepG2 cell line</article-title><source>Zhong Yao Cai</source><volume>31</volume><fpage>1197</fpage><lpage>1200</lpage><year>2008</year><comment>(In Chinese)</comment><pub-id pub-id-type="pmid">19112901</pub-id></element-citation></ref>
<ref id="b35-etm-0-0-5648"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Mao</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>R</given-names></name><name><surname>Jin</surname><given-names>X</given-names></name><name><surname>Ye</surname><given-names>L</given-names></name></person-group><article-title>Anti-tumor effect of &#x03B1;-pinene on human hepatoma cell lines through inducing G2/M cell cycle arrest</article-title><source>J Pharmacol Sci</source><volume>127</volume><fpage>332</fpage><lpage>338</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.jphs.2015.01.008</pub-id><pub-id pub-id-type="pmid">25837931</pub-id></element-citation></ref>
<ref id="b36-etm-0-0-5648"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>C</given-names></name><name><surname>Duan</surname><given-names>W</given-names></name><name><surname>Cen</surname><given-names>B</given-names></name><name><surname>Tan</surname><given-names>J</given-names></name></person-group><article-title>Comparison of chemical components of essential oils in needles of <italic>Pinus massoniana Lamb</italic> and <italic>Pinus elliottottii Engelm</italic> from Guangxi</article-title><source>Se Pu</source><volume>24</volume><fpage>619</fpage><lpage>624</lpage><year>2006</year><comment>(In Chinese)</comment><pub-id pub-id-type="pmid">17288147</pub-id></element-citation></ref>
<ref id="b37-etm-0-0-5648"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>WC</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Gao</surname><given-names>H</given-names></name><name><surname>Jia</surname><given-names>LR</given-names></name><name><surname>He</surname><given-names>Q</given-names></name></person-group><article-title>Chemical composition, antioxidant, and antimicrobial activities of essential oil from pine needle (Cedrus deodara)</article-title><source>J Food Sci</source><volume>77</volume><fpage>C824</fpage><lpage>C829</lpage><year>2012</year><pub-id pub-id-type="doi">10.1111/j.1750-3841.2012.02767.x</pub-id><pub-id pub-id-type="pmid">22757704</pub-id></element-citation></ref>
<ref id="b38-etm-0-0-5648"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peter</surname><given-names>ME</given-names></name></person-group><article-title>Programmed cell death: Apoptosis meets necrosis</article-title><source>Nature</source><volume>471</volume><fpage>310</fpage><lpage>312</lpage><year>2011</year><pub-id pub-id-type="doi">10.1038/471310a</pub-id><pub-id pub-id-type="pmid">21412328</pub-id></element-citation></ref>
<ref id="b39-etm-0-0-5648"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nowsheen</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>ES</given-names></name></person-group><article-title>The intersection between DNA damage response and cell death pathways</article-title><source>Exp Oncol</source><volume>34</volume><fpage>243</fpage><lpage>254</lpage><year>2012</year><pub-id pub-id-type="pmid">23070009</pub-id></element-citation></ref>
<ref id="b40-etm-0-0-5648"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galderisi</surname><given-names>U</given-names></name><name><surname>Jori</surname><given-names>FP</given-names></name><name><surname>Giordano</surname><given-names>A</given-names></name></person-group><article-title>Cell cycle regulation and neural differentiation</article-title><source>Oncogene</source><volume>22</volume><fpage>5208</fpage><lpage>5219</lpage><year>2003</year><pub-id pub-id-type="doi">10.1038/sj.onc.1206558</pub-id><pub-id pub-id-type="pmid">12910258</pub-id></element-citation></ref>
<ref id="b41-etm-0-0-5648"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>XY</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>YJ</given-names></name><name><surname>Li</surname><given-names>YY</given-names></name></person-group><article-title>Pim-3 contributes to radioresistance through regulation of the cell cycle and DNA damage repair in pancreatic cancer cells</article-title><source>Biochem Biophys Res Commun</source><volume>473</volume><fpage>296</fpage><lpage>302</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.bbrc.2016.03.099</pub-id><pub-id pub-id-type="pmid">27016481</pub-id></element-citation></ref>
<ref id="b42-etm-0-0-5648"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>PS</given-names></name><name><surname>Fang</surname><given-names>J</given-names></name><name><surname>Jessop</surname><given-names>L</given-names></name><name><surname>Myers</surname><given-names>T</given-names></name><name><surname>Raj</surname><given-names>P</given-names></name><name><surname>Hu</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Taylor</surname><given-names>PR</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Khan</surname><given-names>J</given-names></name><etal/></person-group><article-title>RAD51B activity and cell cycle regulation in response to DNA damage in breast cancer cell lines</article-title><source>Breast Cancer (Auckl)</source><volume>8</volume><fpage>135</fpage><lpage>144</lpage><year>2014</year><pub-id pub-id-type="pmid">25368520</pub-id></element-citation></ref>
<ref id="b43-etm-0-0-5648"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elmore</surname><given-names>S</given-names></name></person-group><article-title>Apoptosis: A review of programmed cell death</article-title><source>Toxicol Pathol</source><volume>35</volume><fpage>495</fpage><lpage>516</lpage><year>2007</year><pub-id pub-id-type="doi">10.1080/01926230701320337</pub-id><pub-id pub-id-type="pmid">17562483</pub-id></element-citation></ref>
<ref id="b44-etm-0-0-5648"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kastan</surname><given-names>MB</given-names></name><name><surname>Bartek</surname><given-names>J</given-names></name></person-group><article-title>Cell-cycle checkpoints and cancer</article-title><source>Nature</source><volume>432</volume><fpage>316</fpage><lpage>323</lpage><year>2004</year><pub-id pub-id-type="doi">10.1038/nature03097</pub-id><pub-id pub-id-type="pmid">15549093</pub-id></element-citation></ref>
<ref id="b45-etm-0-0-5648"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stark</surname><given-names>GR</given-names></name><name><surname>Taylor</surname><given-names>WR</given-names></name></person-group><article-title>Control of the G2/M transition</article-title><source>Mol Biotechnol</source><volume>32</volume><fpage>227</fpage><lpage>248</lpage><year>2006</year><pub-id pub-id-type="doi">10.1385/MB:32:3:227</pub-id><pub-id pub-id-type="pmid">16632889</pub-id></element-citation></ref>
<ref id="b46-etm-0-0-5648"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stark</surname><given-names>GR</given-names></name><name><surname>Taylor</surname><given-names>WR</given-names></name></person-group><article-title>Analyzing the G2/M checkpoint</article-title><source>Methods Mol Biol</source><volume>280</volume><fpage>51</fpage><lpage>82</lpage><year>2004</year><pub-id pub-id-type="pmid">15187249</pub-id></element-citation></ref>
<ref id="b47-etm-0-0-5648"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Halicka</surname><given-names>HD</given-names></name><name><surname>Traganos</surname><given-names>F</given-names></name><name><surname>Zarebski</surname><given-names>M</given-names></name><name><surname>Dobrucki</surname><given-names>J</given-names></name><name><surname>Darzynkiewicz</surname><given-names>Z</given-names></name></person-group><article-title>Cytometric assessment of DNA damage by exogenous and endogenous oxidants reports aging-related processes</article-title><source>Cytometry A</source><volume>71</volume><fpage>905</fpage><lpage>914</lpage><year>2007</year><pub-id pub-id-type="doi">10.1002/cyto.a.20469</pub-id><pub-id pub-id-type="pmid">17879239</pub-id></element-citation></ref>
<ref id="b48-etm-0-0-5648"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullaart</surname><given-names>E</given-names></name><name><surname>Lohman</surname><given-names>PH</given-names></name><name><surname>Berends</surname><given-names>F</given-names></name><name><surname>Vijg</surname><given-names>J</given-names></name></person-group><article-title>DNA damage metabolism and aging</article-title><source>Mutat Res</source><volume>237</volume><fpage>189</fpage><lpage>210</lpage><year>1990</year><pub-id pub-id-type="doi">10.1016/0921-8734(90)90001-8</pub-id><pub-id pub-id-type="pmid">2079959</pub-id></element-citation></ref>
<ref id="b49-etm-0-0-5648"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lord</surname><given-names>CJ</given-names></name><name><surname>Ashworth</surname><given-names>A</given-names></name></person-group><article-title>The DNA damage response and cancer therapy</article-title><source>Nature</source><volume>481</volume><fpage>287</fpage><lpage>294</lpage><year>2012</year><pub-id pub-id-type="doi">10.1038/nature10760</pub-id><pub-id pub-id-type="pmid">22258607</pub-id></element-citation></ref>
<ref id="b50-etm-0-0-5648"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>SP</given-names></name><name><surname>Bartek</surname><given-names>J</given-names></name></person-group><article-title>The DNA-damage response in human biology and disease</article-title><source>Nature</source><volume>461</volume><fpage>1071</fpage><lpage>1078</lpage><year>2009</year><pub-id pub-id-type="doi">10.1038/nature08467</pub-id><pub-id pub-id-type="pmid">19847258</pub-id></element-citation></ref>
<ref id="b51-etm-0-0-5648"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakkenist</surname><given-names>CJ</given-names></name><name><surname>Kastan</surname><given-names>MB</given-names></name></person-group><article-title>DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation</article-title><source>Nature</source><volume>421</volume><fpage>499</fpage><lpage>506</lpage><year>2003</year><pub-id pub-id-type="doi">10.1038/nature01368</pub-id><pub-id pub-id-type="pmid">12556884</pub-id></element-citation></ref>
<ref id="b52-etm-0-0-5648"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurz</surname><given-names>EU</given-names></name><name><surname>Lees-Miller</surname><given-names>SP</given-names></name></person-group><article-title>DNA damage-induced activation of ATM and ATM-dependent signaling pathways</article-title><source>DNA Repair (Amst)</source><volume>3</volume><fpage>889</fpage><lpage>900</lpage><year>2004</year><pub-id pub-id-type="doi">10.1016/j.dnarep.2004.03.029</pub-id><pub-id pub-id-type="pmid">15279774</pub-id></element-citation></ref>
<ref id="b53-etm-0-0-5648"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norbury</surname><given-names>CJ</given-names></name><name><surname>Zhivotovsky</surname><given-names>B</given-names></name></person-group><article-title>DNA damage-induced apoptosis</article-title><source>Oncogene</source><volume>23</volume><fpage>2797</fpage><lpage>2808</lpage><year>2004</year><pub-id pub-id-type="doi">10.1038/sj.onc.1207532</pub-id><pub-id pub-id-type="pmid">15077143</pub-id></element-citation></ref>
<ref id="b54-etm-0-0-5648"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>BB</given-names></name><name><surname>Elledge</surname><given-names>SJ</given-names></name></person-group><article-title>The DNA damage response: Putting checkpoints in perspective</article-title><source>Nature</source><volume>408</volume><fpage>433</fpage><lpage>439</lpage><year>2000</year><pub-id pub-id-type="doi">10.1038/35044005</pub-id><pub-id pub-id-type="pmid">11100718</pub-id></element-citation></ref>
<ref id="b55-etm-0-0-5648"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Squatrito</surname><given-names>M</given-names></name><name><surname>Brennan</surname><given-names>CW</given-names></name><name><surname>Helmy</surname><given-names>K</given-names></name><name><surname>Huse</surname><given-names>JT</given-names></name><name><surname>Petrini</surname><given-names>JH</given-names></name><name><surname>Holland</surname><given-names>EC</given-names></name></person-group><article-title>Loss of ATM/Chk2/p53 pathway components accelerates tumor development and contributes to radiation resistance in gliomas</article-title><source>Cancer Cell</source><volume>18</volume><fpage>619</fpage><lpage>629</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.ccr.2010.10.034</pub-id><pub-id pub-id-type="pmid">21156285</pub-id></element-citation></ref>
<ref id="b56-etm-0-0-5648"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>J</given-names></name><name><surname>Ferguson</surname><given-names>D</given-names></name><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Bassing</surname><given-names>C</given-names></name><name><surname>Eckersdorff</surname><given-names>M</given-names></name><name><surname>Alt</surname><given-names>FW</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name></person-group><article-title>Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression</article-title><source>Mol Cell Biol</source><volume>25</volume><fpage>661</fpage><lpage>670</lpage><year>2005</year><pub-id pub-id-type="doi">10.1128/MCB.25.2.661-670.2005</pub-id><pub-id pub-id-type="pmid">15632067</pub-id></element-citation></ref>
<ref id="b57-etm-0-0-5648"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinner</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Staudt</surname><given-names>C</given-names></name><name><surname>Iliakis</surname><given-names>G</given-names></name></person-group><article-title>Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin</article-title><source>Nucleic Acids Res</source><volume>36</volume><fpage>5678</fpage><lpage>5694</lpage><year>2008</year><pub-id pub-id-type="doi">10.1093/nar/gkn550</pub-id><pub-id pub-id-type="pmid">18772227</pub-id></element-citation></ref>
<ref id="b58-etm-0-0-5648"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>LJ</given-names></name><name><surname>Yang</surname><given-names>LX</given-names></name></person-group><article-title>Gamma-H2AX-a novel biomarker for DNA double-strand breaks</article-title><source>In Vivo</source><volume>22</volume><fpage>305</fpage><lpage>309</lpage><year>2008</year><pub-id pub-id-type="pmid">18610740</pub-id></element-citation></ref>
<ref id="b59-etm-0-0-5648"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>G</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Zheng</surname><given-names>H</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name></person-group><article-title>MEHP-induced oxidative DNA damage and apoptosis in HepG2 cells correlates with p53-mediated mitochondria-dependent signaling pathway</article-title><source>Food Chem Toxicol</source><volume>50</volume><fpage>2424</fpage><lpage>2431</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.fct.2012.04.023</pub-id><pub-id pub-id-type="pmid">22542555</pub-id></element-citation></ref>
<ref id="b60-etm-0-0-5648"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>SY</given-names></name><name><surname>Lee</surname><given-names>SM</given-names></name><name><surname>Ye</surname><given-names>SK</given-names></name><name><surname>Yoon</surname><given-names>SH</given-names></name><name><surname>Chung</surname><given-names>MH</given-names></name><name><surname>Choi</surname><given-names>J</given-names></name></person-group><article-title>Benzo[a]pyrene-induced DNA damage and p53 modulation in human hepatoma HepG2 cells for the identification of potential biomarkers for PAH monitoring and risk assessment</article-title><source>Toxicol Lett</source><volume>167</volume><fpage>27</fpage><lpage>33</lpage><year>2006</year><pub-id pub-id-type="doi">10.1016/j.toxlet.2006.08.011</pub-id><pub-id pub-id-type="pmid">17029827</pub-id></element-citation></ref>
<ref id="b61-etm-0-0-5648"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Shi</surname><given-names>Q</given-names></name><name><surname>Lehmler</surname><given-names>HJ</given-names></name><name><surname>Fu</surname><given-names>J</given-names></name><name><surname>Su</surname><given-names>C</given-names></name><name><surname>Xia</surname><given-names>X</given-names></name><name><surname>Song</surname><given-names>E</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name></person-group><article-title>Polychlorinated Biphenyl quinone metabolite promotes p53-Dependent DNA damage checkpoint activation, S-Phase cycle arrest and extrinsic apoptosis in human liver hepatocellular carcinoma HepG2 cells</article-title><source>Chem Res Toxicol</source><volume>28</volume><fpage>2160</fpage><lpage>2169</lpage><year>2015</year><pub-id pub-id-type="doi">10.1021/acs.chemrestox.5b00320</pub-id><pub-id pub-id-type="pmid">26451628</pub-id></element-citation></ref>
<ref id="b62-etm-0-0-5648"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Guo</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Hou</surname><given-names>Y</given-names></name></person-group><article-title>The course of uncarinic acid E-induced apoptosis of HepG2 cells from damage to DNA and p53 activation to mitochondrial release of cytochrome c</article-title><source>Biol Pharm Bull</source><volume>29</volume><fpage>1639</fpage><lpage>1644</lpage><year>2006</year><pub-id pub-id-type="doi">10.1248/bpb.29.1639</pub-id><pub-id pub-id-type="pmid">16880619</pub-id></element-citation></ref>
<ref id="b63-etm-0-0-5648"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>SM</given-names></name><name><surname>Jiang</surname><given-names>LP</given-names></name><name><surname>Geng</surname><given-names>CY</given-names></name><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Zhong</surname><given-names>LF</given-names></name></person-group><article-title>Patulin-induced oxidative DNA damage and p53 modulation in HepG2 cells</article-title><source>Toxicon</source><volume>55</volume><fpage>390</fpage><lpage>395</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.toxicon.2009.08.019</pub-id><pub-id pub-id-type="pmid">19744505</pub-id></element-citation></ref>
<ref id="b64-etm-0-0-5648"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname><given-names>K</given-names></name><name><surname>Lin</surname><given-names>T</given-names></name><name><surname>Wei</surname><given-names>J</given-names></name><name><surname>Meng</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Wan</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Chang</surname><given-names>H</given-names></name><etal/></person-group><article-title>Cisplatin induces cell cycle arrest and senescence via upregulating P53 and P21 expression in HepG2 cells</article-title><source>Nan Fang Yi Ke Da Xue Xue Bao</source><volume>33</volume><fpage>1253</fpage><lpage>1259</lpage><year>2013</year><pub-id pub-id-type="pmid">24067199</pub-id></element-citation></ref>
<ref id="b65-etm-0-0-5648"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Ye</surname><given-names>Y</given-names></name><name><surname>Chui</surname><given-names>JH</given-names></name><name><surname>Zhu</surname><given-names>GY</given-names></name><name><surname>Li</surname><given-names>YW</given-names></name><name><surname>Fong</surname><given-names>DW</given-names></name><name><surname>Yu</surname><given-names>ZL</given-names></name></person-group><article-title>Oridonin induces G2/M cell cycle arrest and apoptosis through MAPK and p53 signaling pathways in HepG2 cells</article-title><source>Oncol Rep</source><volume>24</volume><fpage>647</fpage><lpage>651</lpage><year>2010</year><pub-id pub-id-type="pmid">20664969</pub-id></element-citation></ref>
<ref id="b66-etm-0-0-5648"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>H</given-names></name><name><surname>Calvo</surname><given-names>S</given-names></name><name><surname>Greenberg</surname><given-names>K</given-names></name><name><surname>Neall</surname><given-names>Forman L</given-names></name><name><surname>Morrison</surname><given-names>S</given-names></name></person-group><article-title>Information needs in the precision medicine era: How genetics home reference can help</article-title><source>Interact J Med Res</source><volume>5</volume><fpage>e13</fpage><year>2016</year><pub-id pub-id-type="doi">10.2196/ijmr.5199</pub-id><pub-id pub-id-type="pmid">27122232</pub-id></element-citation></ref>
<ref id="b67-etm-0-0-5648"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Hu</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>M</given-names></name></person-group><article-title>Dihydromyricetin suppresses the proliferation of hepatocellular carcinoma cells by inducing G2/M arrest through the Chk1/Chk2/Cdc25C pathway</article-title><source>Oncol Rep</source><volume>30</volume><fpage>2467</fpage><lpage>2475</lpage><year>2013</year><pub-id pub-id-type="doi">10.3892/or.2013.2705</pub-id><pub-id pub-id-type="pmid">24002546</pub-id></element-citation></ref>
<ref id="b68-etm-0-0-5648"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname><given-names>DW</given-names></name><name><surname>Varley</surname><given-names>JM</given-names></name><name><surname>Szydlo</surname><given-names>TE</given-names></name><name><surname>Kang</surname><given-names>DH</given-names></name><name><surname>Wahrer</surname><given-names>DC</given-names></name><name><surname>Shannon</surname><given-names>KE</given-names></name><name><surname>Lubratovich</surname><given-names>M</given-names></name><name><surname>Verselis</surname><given-names>SJ</given-names></name><name><surname>Isselbacher</surname><given-names>KJ</given-names></name><name><surname>Fraumeni</surname><given-names>JF</given-names></name><etal/></person-group><article-title>Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome</article-title><source>Science</source><volume>286</volume><fpage>2528</fpage><lpage>2531</lpage><year>1999</year><pub-id pub-id-type="doi">10.1126/science.286.5449.2528</pub-id><pub-id pub-id-type="pmid">10617473</pub-id></element-citation></ref>
<ref id="b69-etm-0-0-5648"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>Z</given-names></name><name><surname>Chehab</surname><given-names>NH</given-names></name><name><surname>Pavletich</surname><given-names>NP</given-names></name></person-group><article-title>Structure and activation mechanism of the CHK2 DNA damage checkpoint kinase</article-title><source>Mol Cell</source><volume>35</volume><fpage>818</fpage><lpage>829</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.molcel.2009.09.007</pub-id><pub-id pub-id-type="pmid">19782031</pub-id></element-citation></ref>
<ref id="b70-etm-0-0-5648"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nilsson</surname><given-names>I</given-names></name><name><surname>Hoffmann</surname><given-names>I</given-names></name></person-group><article-title>Cell cycle regulation by the Cdc25 phosphatase family</article-title><source>Prog Cell Cycle Res</source><volume>4</volume><fpage>107</fpage><lpage>114</lpage><year>2000</year><pub-id pub-id-type="doi">10.1007/978-1-4615-4253-7_10</pub-id><pub-id pub-id-type="pmid">10740819</pub-id></element-citation></ref>
<ref id="b71-etm-0-0-5648"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nevanlinna</surname><given-names>H</given-names></name><name><surname>Bartek</surname><given-names>J</given-names></name></person-group><article-title>The CHEK2 gene and inherited breast cancer susceptibility</article-title><source>Oncogene</source><volume>25</volume><fpage>5912</fpage><lpage>5919</lpage><year>2006</year><pub-id pub-id-type="doi">10.1038/sj.onc.1209877</pub-id><pub-id pub-id-type="pmid">16998506</pub-id></element-citation></ref>
<ref id="b72-etm-0-0-5648"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>JA</given-names></name><name><surname>Fomous</surname><given-names>C</given-names></name><name><surname>Fun</surname><given-names>J</given-names></name></person-group><article-title>Challenges and strategies of the Genetics Home Reference</article-title><source>J Med Libr Assoc</source><volume>94</volume><fpage>336</fpage><lpage>342</lpage><year>2006</year><pub-id pub-id-type="pmid">16888669</pub-id></element-citation></ref>
<ref id="b73-etm-0-0-5648"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Chang</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Traditional Chinese medicine in cancer care: A review of controlled clinical studies published in chinese</article-title><source>PLoS One</source><volume>8</volume><fpage>e60338</fpage><year>2013</year><pub-id pub-id-type="doi">10.1371/journal.pone.0060338</pub-id><pub-id pub-id-type="pmid">23560092</pub-id></element-citation></ref>
<ref id="b74-etm-0-0-5648"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nie</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Deng</surname><given-names>LI</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Pang</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name></person-group><article-title>Efficacy of traditional Chinese medicine in treating cancer</article-title><source>Biomed Rep</source><volume>4</volume><fpage>3</fpage><lpage>14</lpage><year>2016</year><pub-id pub-id-type="doi">10.3892/br.2015.537</pub-id><pub-id pub-id-type="pmid">26870326</pub-id></element-citation></ref>
<ref id="b75-etm-0-0-5648"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name></person-group><article-title>Advancement in the treatment of diminished ovarian reserve by traditional Chinese and Western medicine</article-title><source>Exp Ther Med</source><volume>11</volume><fpage>1173</fpage><lpage>1176</lpage><year>2016</year><pub-id pub-id-type="doi">10.3892/etm.2016.3025</pub-id><pub-id pub-id-type="pmid">27073418</pub-id></element-citation></ref>
<ref id="b76-etm-0-0-5648"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>T</given-names></name><name><surname>Pan</surname><given-names>H</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name></person-group><article-title>Petroleum ether extract of Chenopodium album L. prevents cell growth and induces apoptosis of human lung cancer cells</article-title><source>Exp Ther Med</source><volume>12</volume><fpage>3301</fpage><lpage>3307</lpage><year>2016</year><pub-id pub-id-type="doi">10.3892/etm.2016.3765</pub-id><pub-id pub-id-type="pmid">27882153</pub-id></element-citation></ref>
<ref id="b77-etm-0-0-5648"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>CC</given-names></name></person-group><article-title>Tanshinone IIA potentiates the efficacy of 5-FU in Colo205 colon cancer cells in vivo through downregulation of P-gp and LC3-II</article-title><source>Exp Ther Med</source><volume>3</volume><fpage>555</fpage><lpage>559</lpage><year>2012</year><pub-id pub-id-type="doi">10.3892/etm.2011.441</pub-id><pub-id pub-id-type="pmid">22969929</pub-id></element-citation></ref>
<ref id="b78-etm-0-0-5648"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tai</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>YM</given-names></name><name><surname>Zou</surname><given-names>X</given-names></name><name><surname>Pan</surname><given-names>Q</given-names></name><name><surname>Lan</surname><given-names>YD</given-names></name><name><surname>Huo</surname><given-names>Q</given-names></name><name><surname>Zhu</surname><given-names>JW</given-names></name><name><surname>Guo</surname><given-names>F</given-names></name><name><surname>Zheng</surname><given-names>CQ</given-names></name><name><surname>Wu</surname><given-names>CZ</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name></person-group><article-title>Effect of Polygonatum odoratum extract on human breast cancer MDA-MB-231 cell proliferation and apoptosis</article-title><source>Exp Ther Med</source><volume>12</volume><fpage>2681</fpage><lpage>2687</lpage><year>2016</year><pub-id pub-id-type="doi">10.3892/etm.2016.3630</pub-id><pub-id pub-id-type="pmid">27698772</pub-id></element-citation></ref>
<ref id="b79-etm-0-0-5648"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoai</surname><given-names>NT</given-names></name><name><surname>Duc</surname><given-names>HV</given-names></name><name><surname>do Thao</surname><given-names>T</given-names></name><name><surname>Orav</surname><given-names>A</given-names></name><name><surname>Raal</surname><given-names>A</given-names></name></person-group><article-title>Selectivity of <italic>Pinus sylvestris</italic> extract and essential oil to estrogen-insensitive breast cancer cells Pinus sylvestris against cancer cells</article-title><source>Pharmacogn Mag</source><volume>11</volume><supplement>Suppl 2</supplement><fpage>S290</fpage><lpage>S295</lpage><year>2015</year><pub-id pub-id-type="doi">10.4103/0973-1296.166052</pub-id><pub-id pub-id-type="pmid">26664017</pub-id></element-citation></ref>
<ref id="b80-etm-0-0-5648"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blackford</surname><given-names>AN</given-names></name><name><surname>Jackson</surname><given-names>SP</given-names></name></person-group><article-title>ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response</article-title><source>Mol Cell</source><volume>66</volume><fpage>801</fpage><lpage>817</lpage><year>2017</year><pub-id pub-id-type="doi">10.1016/j.molcel.2017.05.015</pub-id><pub-id pub-id-type="pmid">28622525</pub-id></element-citation></ref>
<ref id="b81-etm-0-0-5648"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paull</surname><given-names>TT</given-names></name></person-group><article-title>Mechanisms of ATM activation</article-title><source>Annu Rev Biochem</source><volume>84</volume><fpage>711</fpage><lpage>738</lpage><year>2015</year><pub-id pub-id-type="doi">10.1146/annurev-biochem-060614-034335</pub-id><pub-id pub-id-type="pmid">25580527</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-etm-0-0-5648" position="float">
<label>Figure 1.</label>
<caption><p>Treatment with pine needle oil induces cell cycle arrest at the G2/M phase in HepG2 cells. The HepG2 cells were treated with pine needle oil at different concentrations and DMSO as a vehicle control for 48 h, followed by flow cytometry analysis to determine the phase distribution in the cell cycle. The data revealed that pine needle oil induced G2/M arrest in a dose-dependent manner. DMSO, dimethyl sulfoxide.</p></caption>
<graphic xlink:href="etm-15-02-1975-g00.tif"/>
</fig>
<fig id="f2-etm-0-0-5648" position="float">
<label>Figure 2.</label>
<caption><p>Key proteins involved in the ATM pathway are activated by treatment with pine needle oil. HepG2 cells treated with dimethyl sulfoxide or pine needle oil at various concentrations were lysed and analyzed by western blotting. p-ATM (S1981), p-CHK2 (T68), p-p53, p53 and &#x03B3;-H2AX were evidently upregulated in HepG2 cells following treatment with pine needle oil. Additionally, &#x03B2;-actin was used as a loading control. p, phosphorylated; ATM, ataxia-telangiectasia mutated; H2AX, H2A histone family; CHK2, checkpoint kinase 2; CDC25C, cell division cycle 25C.</p></caption>
<graphic xlink:href="etm-15-02-1975-g01.tif"/>
</fig>
<fig id="f3-etm-0-0-5648" position="float">
<label>Figure 3.</label>
<caption><p>Treatment with pine needle oil enhances the nuclear expression of &#x03B3;-H2AX. The nucleus was stained with DAPI. The treatment of pine needle oil markedly enhanced the nuclear expression of &#x03B3;-H2AX (red) in HepG2 cells in a dose-dependent manner. H2AX, H2A histone family, member X; DMSO, dimethyl sulfoxide; DAPI, 4&#x2032;,6-diamidino-2-phenylindole. Magnification, &#x00D7;400.</p></caption>
<graphic xlink:href="etm-15-02-1975-g02.tif"/>
</fig>
<table-wrap id="tI-etm-0-0-5648" position="float">
<label>Table I.</label>
<caption><p>Cell cycle analysis of HepG2 cells treated with pine needle oil.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="bottom" colspan="3">Percentage of cells in each cell cycle phase in each treatment group</th>
</tr>
<tr>
<th/>
<th align="center" valign="bottom" colspan="3"><hr/></th>
</tr>
<tr>
<th align="left" valign="bottom">Cell cycle phase</th>
<th align="center" valign="bottom">Dimethyl sulfoxide</th>
<th align="center" valign="bottom">Pine needle oil (0.16 mg/ml)</th>
<th align="center" valign="bottom">Pine needle oil (5.12 mg/ml)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">G1</td>
<td align="center" valign="top">61.5&#x00B1;5.2</td>
<td align="center" valign="top">47.4&#x00B1;3.9<sup><xref rid="tfn2-etm-0-0-5648" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">43.2&#x00B1;1.3<sup><xref rid="tfn3-etm-0-0-5648" ref-type="table-fn">b</xref>,<xref rid="tfn4-etm-0-0-5648" ref-type="table-fn">c</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">S</td>
<td align="center" valign="top">21.5&#x00B1;4.4</td>
<td align="center" valign="top">17.2&#x00B1;2.4<sup><xref rid="tfn2-etm-0-0-5648" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">11.3&#x00B1;1.6<sup><xref rid="tfn3-etm-0-0-5648" ref-type="table-fn">b</xref>,<xref rid="tfn4-etm-0-0-5648" ref-type="table-fn">c</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">G2/M</td>
<td align="center" valign="top">17.0&#x00B1;1.1</td>
<td align="center" valign="top">35.4&#x00B1;3.4<sup><xref rid="tfn2-etm-0-0-5648" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">45.5&#x00B1;2.1<sup><xref rid="tfn3-etm-0-0-5648" ref-type="table-fn">b</xref>,<xref rid="tfn4-etm-0-0-5648" ref-type="table-fn">c</xref></sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn1-etm-0-0-5648"><p>Data were produced from three independent experiments and are presented as the mean &#x00B1; standard error of the mean.</p></fn>
<fn id="tfn2-etm-0-0-5648"><label>a</label><p>P&#x003C;0.05 low dose pine needle oil group vs. DMSO group</p></fn>
<fn id="tfn3-etm-0-0-5648"><label>b</label><p>P&#x003C;0.05 high dose pine needle oil group vs. DMSO group</p></fn>
<fn id="tfn4-etm-0-0-5648"><label>c</label><p>P&#x003C;0.05 high dose pine needle oil group vs. low dose pine needle oil group.</p></fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
